---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-004096"
form_type: "8-K"
ticker: "BCRX"
cik: "0000882796"
company_name: "BIOCRYST PHARMACEUTICALS INC"
filed_at: "2026-06-12T20:10:10+00:00"
generated_at: "2026-06-12T20:23:14.923504+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioCryst shareholders approve 7M share increase to Stock Incentive Plan

## Summary
- Incentive Plan approved with 119.8M for, 63.3M against, adding 7M shares to the Plan.
- Directors Heggie, McKee, Stonehouse re-elected; each received >170M votes for.
- Non-binding say-on-pay passed but 56.8M (31% of votes cast) voted against.
- Ernst & Young ratified as 2026 auditor with 210.3M votes for, 7.2M against.
- 34.0M broker non-votes recorded on director elections, say-on-pay, and plan vote.

## SEC filing metadata
- accession: 0001171843-26-004096
- form_type: 8-K
- ticker: BCRX
- cik: 0000882796
- company_name: BIOCRYST PHARMACEUTICALS INC
- filed_at: 2026-06-12T20:10:10+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882796/000117184326004096/0001171843-26-004096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882796/000117184326004096/f8k_061226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-004096
- JSON: https://secwatch.observer/filing/0001171843-26-004096.json
- Plain text: https://secwatch.observer/filing/0001171843-26-004096.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.